Business Standard

Strides Shasun buys Moberg Pharma's PediaCare brand for $ 5 mn

With this acquisition, the company has strengthen its consumer healthcare portfolio

Lupin gets US FDA nod for antibacterial drug azithromycin suspension

BS B2B Bureau Mumbai
Strides Arcolab International Ltd, the UK-based wholly-owned subsidiary of Strides Shasun Ltd, has entered into an agreement with Swedish firm Moberg Pharma to acquire the PediaCare brand for a total consideration of $ 5 million.
 
PediaCare is an established paediatric cough, cold and allergy brand with annual sales of approximately $ 6 million. PediaCare will form an important part of Strides expanding consumer health care portfolio and brings with it expertise in the paediatric segment as well as a strong brand name with global potential.
 
The Bengaluru-headquartered Strides Shasun Ltd has global manufacturing foot print with 13 production facilities spread across three continents including 5 US FDA approved facilities and 8 facilities for the emerging markets. The company has three dedicated R&D facilities in India with global filing capabilities and a strong commercial footprint across 85 countries.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 26 2016 | 11:51 AM IST

Explore News